Bifeprunox Mesylate
- N ° de catalogue:A929992
- N ° CAS. : 350992-13-1
- Formule moléculaire:C25H27N3O5S
- Masse moléculaire: 481.57
Remarque*
1. Please click the to confirm the discount and stock quantity.
2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Enquête en vrac
1. Please click the to confirm the discount and stock quantity.
2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Contrôle de qualité&SDS
détails du produit
Numero CAS | 350992-13-1 | Apparence | |
Numéro de catalogue | A929992 | Numéro MDL | |
Formule moléculaire | C25H27N3O5S | Masse moléculaire | 481.57 |
Point d'ébullition | Point de fusion | ||
Point de rupture | Densité | ||
Synonymes | 7-[4-([1,1'-Biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate | ||
Condition de stockage | Store in a tightly closed container,in a cool and dry place |
sécurité
Pictogramme SGH | |||
Mot de signal | Warning | Numéro UN | |
Mentions de danger | Classe | ||
Conseils de prudence | Groupe d'emballage |
La description
P7C3-A20 is an analogue of P7C3, and is a proneurogenic, neuroprotective agent. P7C3-A20 displayed increased activity and an improved toxicity profile compared to P7C3. P7C3-A20 demonstrated greater proneurogenic efficacy than a wide spectrum of currently marketed antidepressant drugs. P7C3-A20 showed neuroprotective properties in rodent models of Parkinson's disease, amyotrophic lateral sclerosis, traumatic brain injury and age-related cognitive decline. |